apointed
-
Recon
Histogenics Corporation Announces Appointment of Stephen Kennedy to Chief Technology Officer
WALTHAM, Mass., July 30, 2015 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and…
Read More »